Gallstone disease screening: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 2: Line 2:
{{Gallstone disease}}
{{Gallstone disease}}


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{HM}]
==Overview==
==Overview==
Early treatment of Gallstone disease decreases the morbidity or avoids further cholecystectomy, which in turn may offset the need for screening, since patients would have to finance an  it may save clinical care costs in later disease periods sufficiently to offset the screening and early treatment costs. In addition, whether routine screening for GSD is worthwhile depends on whether patients are willing to pay the ultrasonography screening cost that would reduce the risk of cholecystectomy.


There is insufficient evidence to recommend routine screening for [disease/malignancy].
There is insufficient evidence to recommend routine screening for [disease/malignancy].

Revision as of 15:28, 27 November 2017

Gallstone disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gallstone disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Lithotripsy
Surgical management

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gallstone disease screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gallstone disease screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gallstone disease screening

CDC on Gallstone disease screening

Gallstone disease screening in the news

Blogs on Gallstone disease screening

Directions to Hospitals Treating Gallstone disease

Risk calculators and risk factors for Gallstone disease screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: {{HM}]

Overview

Early treatment of Gallstone disease decreases the morbidity or avoids further cholecystectomy, which in turn may offset the need for screening, since patients would have to finance an it may save clinical care costs in later disease periods sufficiently to offset the screening and early treatment costs. In addition, whether routine screening for GSD is worthwhile depends on whether patients are willing to pay the ultrasonography screening cost that would reduce the risk of cholecystectomy.



There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].

Screening

  • There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

  • According to the [guideline name], screening for [disease name] is not recommended.

OR

  • According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
    • [Condition 1]
    • [Condition 2]
    • [Condition 3]

References

Template:WH Template:WS